| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 30,950,000 | 27,451,000 | 27,351,000 | 28,800,000 | | Cost of Revenue | 23,851,000 | 20,855,000 | 20,835,000 | 21,983,000 | | | Gross Profit | 7,099,000 | 6,596,000 | 6,516,000 | 6,817,000 | | | Operating Expenses | | Research Development | 704,000 | 667,000 | 716,000 | 732,000 | | Selling General and Administrative | 2,966,000 | 2,874,000 | 2,794,000 | 2,979,000 | | Non Recurring | 99,000 | 421,000 | 169,000 | 200,000 | | Others | 400,000 | 379,000 | 380,000 | 412,000 | | | | Total Operating Expenses | 4,169,000 | 4,341,000 | 4,059,000 | 4,323,000 | | | | Operating Income or Loss | 2,930,000 | 2,255,000 | 2,457,000 | 2,494,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 194,000 | (194,000) |
-
| | Earnings Before Interest And Taxes | 2,209,000 | 2,449,000 | 2,263,000 | 2,494,000 | | Interest Expense | (840,000) | 452,000 | 156,000 | 232,000 | | Income Before Tax | 3,049,000 | 1,997,000 | 2,107,000 | 2,262,000 | | Income Tax Expense | 601,000 | 355,000 | 391,000 | 408,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,448,000 | 1,642,000 | 1,716,000 | 1,854,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,448,000 | 1,642,000 | 1,716,000 | 1,854,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,448,000 | $1,642,000 | $1,716,000 | $1,854,000 |
|
0.51% Nasdaq 
Income Statement
